Setayesh L, Haghighat N, Rasaei N, Rezaei M, Casazza K, Nadery M · Diabetes Metab Syndr (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
25 peer-reviewed studies
What the evidence says
Amla doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 2014–2026 with a typical study size of 40 participants.
Based on 25 studies · 2 meta-analyses · 12 RCTs · 40 total participants
Confidence
High confidenceBy outcome
19 studies in the last 5 years · Latest meta-analysis: 2023
Setayesh L, Haghighat N, Rasaei N, Rezaei M, Casazza K, Nadery M · Diabetes Metab Syndr (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Brown PDS, Ketter N, Vis-Dunbar M, Sakakibara BM · BMC Complement Med Ther (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Li G, Yu Q, Li M, Zhang D, Yu J, Yu X · Food Funct (2023)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Huang HZ, Qiu M, Lin JZ, Li MQ, Ma XT, Ran F · Eur J Nutr (2021)
No plain-language summary recorded for this citation — open the paper to read its abstract.
In plain English: Notably, plant-derived compounds, i.e., Ginkgo biloba, have demonstrated promise in promoting repigmentation and managing disease progression.
Diaz MJ, Tran JT, Rose D, Wei A, Lakshmipathy D, Lipner SR. · Nutrients (2025)
Uchiyama T, Tsunenaga M, Miyanaga M, Ueda O, Ogo M · Biotechnol Appl Biochem (2019)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Grover S, Tewari S, Sharma RK, Singh G, Yadav A, Naula SC · Phytother Res (2016)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Usharani P, Merugu PL, Nutalapati C · BMC Complement Altern Med (2019)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Upadya H, Prabhu S, Prasad A, Subramanian D, Gupta S, Goel A · BMC Complement Altern Med (2019)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Fatima N, Pingali U, Muralidhar N · Phytomedicine (2014)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Martinez V, McAngus K, Dickerson BL, Leonard M, Chavez E, Chun J · Nutrients (2025)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Lu C, Qing L, Yina L · J Appl Oral Sci (2024)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, Bozorgi M, Heydarirad G, Nazem E · J Integr Med (2018)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Varnasseri M, Siahpoosh A, Hoseinynejad K, Amini F, Karamian M, Yad MJY · Complement Ther Med (2022)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Ishaq S, H Rizwani G, Shareef H, Fatima S, Anser H, Sarfraz S · Pak J Pharm Sci (2021)
No plain-language summary recorded for this citation — open the paper to read its abstract.
Shanmugarajan D, Girish C, Harivenkatesh N, Chanaveerappa B, Prasanna Lakshmi NC · Phytother Res (2021)
No plain-language summary recorded for this citation — open the paper to read its abstract.
In plain English: Overall, aonla is a valuable fruit with significant potential for use in improving human health.
Avinash PG, Hamid, Shams R, Dash KK, Shaikh AM, Ungai D, Harsányi E, Suthar T, Kovács B. · Plants (Basel, Switzerland) (2024)
In plain English: We have discussed its key bioactive molecules, presented evidence of its diverse pharmacological activities, examined its relevance to current disease groups, and outlined future research directions in detail.
Thallada V, Monika N, Dinesh T, Kusuma G, Ghosh K, Chitra S. · Chemistry & biodiversity (2026)
In plain English: All things considered, Phyllanthus Emblica shows great promise as a natural resource with significant applications in complementary and alternative medicine and pharmacological research.
Pathak S, Pratap A, Sharma R, Jha MK. · Current topics in medicinal chemistry (2024)
In plain English: Superfoods prevent chronic illnesses and improve health.
Mittal RK, Sharma V, Krishna G. · Current drug discovery technologies (2025)